Ipsen's Stock Hits a Historical High at €169.40, Up 82% Over the Year

New Record Set in Morning Trading

In mid-morning trading, Ipsen set a new absolute record at €169.40, surpassing the previous peak of €168.10 recorded on April 7. The stock now shows an impressive performance of 82.15% over the year and nearly 33% over the last three months, illustrating a sustained upward trajectory. This movement occurs in a context of a stable Parisian market: the CAC 40 slightly increased by 0.20% during the session to 8,262.65 points, while the SBF 120 advanced by 0.23%. In the pharmaceutical sector, comparable companies show moderate variations: Sanofi is up by 0.41% and UCB by 0.96%, amplitudes much lower than that of Ipsen this Friday. The upcoming quarterly publication on April 16 is a key event marked on the group's financial calendar, followed by the general assembly scheduled on May 13.

Technical Analysis Indicates Potential Overbuy

From a technical analysis perspective, the current price of €169.40 is above the upper Bollinger band limit set at €167.72, indicating a potential overbuy signal. This breach means that the stock is moving in an extreme zone relative to its recent volatility, a zone that historically could precede either a consolidation or a continuation of the movement if there is a strong fundamental catalyst. Moreover, the 50-day moving average stands at €153.07, significantly below the current price, confirming the medium-term upward trend. The gap with the 200-day moving average (€126.47) exceeds 42 euros, highlighting the magnitude of the rally accumulated over the year. The RSI, at 59, is not yet in a marked overbuy zone according to this indicator (threshold generally set at 70), which slightly moderates the signal emitted by the Bollinger bands. The next resistance threshold identified was at €167.40, a level now surpassed during the session.